Friday, April 3, 2026

Korea’s Network Fee Fight Could Turn Into a U.S. Tariff Case: 42% of Traffic, $150M–$244M in Potential Google Fees

U.S. tariffs threaten South Korea's network usage fees for global content providers, raising trade and investment concerns amid digital policy scrutiny.

Oracle Signs $300B Cloud Deal With OpenAI, Fueling AI Gold Rush

Oracle signs a $300 billion deal with OpenAI for computing power, marking the largest cloud contract and boosting AI investments.

How the Late Lee Kun-hee’s 700 Billion Won Donation is Transforming Infectious Disease Research in Korea

The KDCA will host two international symposia on infectious disease research to enhance collaboration and response capabilities starting March 26.

Tag: p53 Y220C mutation

LG Chem’s FMC-220: A Breakthrough Cancer Drug Targeting the p53 Y220C Mutation

LG Chem secures exclusive rights to FMC-220, a cancer drug targeting the p53 Y220C mutation, aiming for Phase 1 trials.

Top News

- Our Sponsors Ad -

Follow us